Direct targeted therapy for MLL‐fusion‐driven high‐risk acute leukaemias.
Saved in:
| Title: | Direct targeted therapy for MLL‐fusion‐driven high‐risk acute leukaemias. |
|---|---|
| Authors: | Cantilena, Sandra1 (AUTHOR), Gasparoli, Luca1 (AUTHOR), Pal, Deepali2 (AUTHOR), Heidenreich, Olaf2 (AUTHOR), Klusmann, Jan‐Henning3 (AUTHOR), Martens, Joost H. A.4 (AUTHOR), Faille, Alexandre5,6,7 (AUTHOR), Warren, Alan J.5,6,7 (AUTHOR), Karsa, Mawar8,9 (AUTHOR), Pandher, Ruby8,9 (AUTHOR), Somers, Klaartje8,9 (AUTHOR), Williams, Owen1 (AUTHOR), de Boer, Jasper1 (AUTHOR) j.boer@ucl.ac.uk |
| Source: | Clinical & Translational Medicine. Jun2022, Vol. 12 Issue 6, p1-19. 19p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20011326 |
|---|---|
| DOI: | 10.1002/ctm2.933 |